Observational
Trials are also important to moving scientific knowledge forward. Archer Eller
also discussed a study funded by a grant called ROMII to study microaspirations
(GERD/Reflux) and ILD.
The study
includes:
30 people
with other ILDs other than IPF
30 people
with IPF
60 healthy
people
They are
primarily using a Bravo capsule that will be clipped onto the esophagus as a
transmitter and the patients will use a pager. Eventually, the transmitter will
detach and be flushed through the system. This is the study I was invited to
join, though I did not qualify. I had a Nissen Findoplication, which stops
GERD.
There has
long been the question of which came first – Interstitial lung disease or GERD.
Fibrosis or inflammation.
The study
will involve IPF patients, which is a restrictive lung disease that changes the
lung to become stiff. The thought is that while it is growing stiff, it is
pulling away from the connection at the end of the esophagus. They also are
looking at connective tissue diseases like lupus, scleroderma and arthritis to
see if they also show signs of GERD and this “pulling” away from this
connection causing stomach acids or microaspirations to enter the lungs.
And
finally, the question of whether everyone has some sort of aspirations.
We also
learned there is another observational study looking at Biomarkers. They
are looking at telomeres in patients DNA. Interesting.
Next month,
a woman I met at the Lung Transplant clinic will be speaking to us regarding
that process which I have detailed beginning here:
Finally,
there was a woman sitting in the back of the room and was quiet until the end.
We notice that when a new person joins the group, they need to tell their
story. It is good for them. We are a group who can offer support and our own
experiences to help a new member. She was really needing help.
She
announced that she is one year away from lung transplants but is not able to move
forward in the process because she just couldn’t get under the mandatory 30
BMI. I raised my hand and told her that I had help for her and that we would
talk after the meeting.
She is a
patient of Kaiser. I spoke with her briefly, told her to ask her doctor for a
referral to the ILD Clinic. She was worried about who would pay for this change
and another member of the support group talked about his experience being a
Kaiser patient. She would still be a Kaiser patient even though she is being
seen at the ILD Clinic. Next, I told her about my experience at the Weight
Management Clinic and told her to ask for a referral from the ILD Clinic at her
first appointment.
It gave her
hope.
No comments:
Post a Comment